










The Centre for Health Economics Research and Evaluation (CHERE) was 
established in 1991.  CHERE is a centre of excellence in health economics and 
health services research. It is a joint Centre of the Faculties of Business 
and Nursing, Midwifery and Health at the University of Technology, Sydney, in 
collaboration with Central Sydney Area Health Service. It was established as a 
UTS Centre in February, 2002. The Centre aims to contribute to the development 
and application of health economics and health services research through 
research, teaching and policy support. CHERE’s research program encompasses 
both the theory and application of health economics. The main theoretical 
research theme pursues valuing benefits, including understanding what 
individuals value from health and health care, how such values should be 
measured, and exploring the social values attached to these benefits. The 
applied research focuses on economic and the appraisal of new programs or new 
ways of delivering and/or funding services. CHERE’s teaching includes 
introducing clinicians, health services managers, public health professionals 
and others to health economic principles. Training programs aim to develop 
practical skills in health economics and health services research. Policy 
support is provided at all levels of the health care system by undertaking 
commissioned projects, through the provision of formal and informal advice as 
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1.  Introduction 
It is widely acknowledged that designing and implementing health care services 
which aim to prevent and manage chronic conditions represents a challenge for all 
health systems, including the Australian health care system. However, it is a challenge 
that must be met if the Australian health system of the future is to maintain its 
reputation of providing care that is relatively accessible, of high quality and 
satisfactory to most recipients.  
 
In this respect, funding and organisation of services for chronic conditions are of 
particular concern as the current system, designed to address acute episodes of illness 
or injury is, from the perspective of dealing with chronic conditions, fragmented. 
Medicare is limited to mostly medical services and, due to rising pout-of-pocket costs 
in the form of co-payments, access to specialist medical services is not as equitable as 
is access to general practice. In recent years, additional MBS items have included care 
provided by some allied health professionals for some conditions and 
multidisciplinary care has been recognised as an essential element of care for chronic 
conditions, but the fee-for-service funding mechanism is generally a clumsy and 
inefficient means of encouraging the organisation and delivery of services of the 
highest quality, that is on a coordinated and integrated basis.  
 
A twenty-first century health system has to be able to deal with new ways of 
delivering services, using new technologies. A number of design features of the 
Medicare system, which were appropriate at the time it commenced operation may 
represent barriers to the provision of integrated care. The Medicare system has been 
designed to focus on face-to- face delivery of services, whereas modern technology 
allows for different forms of delivery. For example, the use of pacemakers in cardiac 
patients is well accepted. These must be checked for correct functioning and allow 
monitoring of new occurrences of arrhythmia. It is technically possible to install 
devices in the patient’s home which read data from the pacemaker, transmit it through 
broadband connections to a data base, where the data are analysed, and when 
exceptional results or patterns are detected, an email is sent to the responsible 
provider, who can then adjust the therapy perhaps by phoning the patient. This is 
technically possible (though effectiveness has not yet been established); but it would 
not be funded in the current health system. The monitoring device may be paid by an 
insurer, if the patient has private insurance. The doctor would not be paid by 
Medicare, as there has been no face to face encounter. The broadband connection, the 
data bank and the analytical capacity do not fit any existing funding program. And 
nowhere is the responsibility and incentive to co-ordinate the process. 
 
Another important feature of the Medicare system is that it is more conducive to 
patient initiated encounters than ongoing management and provides even fewer 
incentives for providers to focus on preventing illness. Whilst management is an 
important aspect of a system designed for chronic conditions, secondary prevention 
(ie management of risk factors such as hypertension, obesity and smoking and 
prevention of complications in established disease, such as retinopathy in diabetes) is 
at least as important as treating a condition once it becomes established.  
 
Numerous countries are facing similar challenges to improving the effectiveness and 
efficiency of the health care system’s ability to deal with chronic diseases.  In their 
recent publication on the role of care coordination in improving health system 
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performance, the OECD suggests that consideration be given to new models of 
ambulatory care, that resources dedicated to this sector be reviewed, and that care 
coordination would be facilitated by wider use of IT and more system wide 
integration (OECD 2007). 
 
Both the Australian and State/Territory governments have recognised these challenges 
and a number of projects designed to investigate the means to and outcomes of 
coordination and/or integration of services have been published. After the results of 
the Coordinated Care trials indicated that there were a number of important barriers to 
achieving the goals of the trials, ideas and research concerning integration, integrated 
care and integrated services delivery models have gained increasing attention from 
Australian policy makers, planners and service providers. 
 
The recently released final report of the National Health and Hospitals Reform 
Commission argued that voluntary enrolment in a primary health service-based 
“health care home” which would help coordinate, guide and navigate access to the 
right range of multidisciplinary health service providers was their recommended 
means of encouraging better continuity and coordinated care for people with more 
complex health problems. This recommendation echoes recent literature emanating 
from the United States in which the medical home is envisaged as being able to more 
effectively support the core functions of primary care and management of chronic 
disease (Fisher 2008).  
 
This paper is designed as an issues paper. Its aim is to set out what evidence is 
available regarding the effectiveness and efficiency of funding, organisation and 
delivery of services directed at preventing and managing chronic conditions, and 
identify what further information is required. The latter will then be used as a means 
of identifying gaps in information which can be addressed by research. The 
information is not presented as a comprehensive review of all available evidence but 
as a preliminary scoping of the results of the most recent literature.  
 
The methods used to address the issues outlined below are discussed briefly in 
Section 2. 
 
The issues addressed in the paper are organised around the following questions: 
•  What are chronic conditions? Which ones should be managed in an organised 
way within the Australian health care system? This is addressed in Section 3. 
•  What is the evidence for the effectiveness and cost effectiveness of initiatives 
targeting secondary prevention and management of chronic conditions at the 
level of both the health system (policy level) and health services (organisation 
and provider levels)? These issues are discussed in Section 4. 
•  What are the challenges in designing and implementing interventions, services 
and programs for preventing and managing these conditions? Section 5 
presents a framework for the secondary prevention and management of 
chronic conditions. 
 
Sections 6 and 7 are short summaries of the issues identified in the Paper and a list of 
identified research questions, respectively. 
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2.  Methods 
The methods used include a preliminary review of the evidence regarding the funding, 
organisation and delivery of services designed to manage individuals who have 
developed risk factors for chronic conditions (secondary prevention) and those who 
have established disease. Most evidence is available regarding organisational and 
delivery aspects of services targeting chronic conditions. No trial evidence is available 
regarding funding. However, some suggestions have been published and the 
information provided in this previous work will be used to develop the proposed 
research strategy. 
 
An initial literature search was undertaken, using Embase, with the key words 
‘chronic care models,’ ‘chronic care management’, and ‘disease management’. 
Limiting the results to publications in English, published since 2000, and removing 
duplicates yielded 6581 publications. This demonstrates that this is a complex and 
large topic area. The literature was further limited by selecting a sample of reviews 
and studies from the UK, UK and Europe and Australia which focussed on funding, 
organisational and delivery issues so that a representative set of issues could be 
identified and the current evidence summarised.  
 
For the purposes of this paper, a formal systematic review was not undertaken, 
although the results of some published reviews have been used.  
 
3.  What are chronic conditions? 
 
Chronic conditions are those which are long lasting and persistent. They often have 
multiple and complex risk factors, many of which are common to several conditions. 
They usually develop over a long time, and, once established, are seldom able to be 
completely cured. Most are characterised by phases of acute illness followed by 
remissions. They may be associated with the development of complications which 
may lead to functional impairment and disability. Their presence is likely to 
complicate the treatment of other illnesses.  
 
The AIHW reports that there is a high prevalence of chronic conditions, with 77% of 
Australians having at least one. However, the prevalence and incidence data are 
imprecise, as they are largely drawn from self-reporting in the National Health 
Survey, which in turn relies on respondents having been given a diagnosis. Exceptions 
are cancer (as data are provided by Cancer Registries and cancer is a notifiable 
disease) and severe kidney disease (as the renal physicians maintain a specialised 
registry for dialysis and transplant patients). A survey of individuals with at least one 
of seven chronic conditions undertaken by the Commonwealth Fund (Schoen et al 
2008) indicated that 63% of participants had two or more of the seven conditions 
(hypertension, heart disease, diabetes, arthritis, lung problems, depression and 
cancer). 
 
Most studies of chronic conditions generally study those which are relatively serious 
in terms of their impact on at least two of the following aspects: pain, function, 
quality of life, mortality, utilisation of health services and ability to work. Such 
conditions tend to include at least some of the following: arthritis, asthma, 
cardiovascular disease, cerebrovascular disease, chronic kidney disease, chronic 
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obstructive pulmonary disease, colorectal cancer, diabetes, lung cancer, oral disease, 
osteoporosis, and depression. Diabetes, COPD and some cardiovascular diseases (eg 
chronic heart failure) are amongst the most commonly studied.  
 
Undertaking research into appropriate models of care also requires that there be 
suitable interventions able to prevent and/or manage the condition. 
 
Thus, the 77% prevalence of chronic conditions reported by the AIHW may include 
some conditions which, whilst chronic according to the definition of being long 
lasting and persistent, may not have major impacts on health or utilisation of services 
or (perhaps more importantly) may either not be amenable to prevention or be able to 
be managed by relatively simple medical means and/or self-management. Conditions 
such as hay-fever, psoriasis, some allergies and some chronic gastrointestinal diseases 
may fall into this category. 
 
Chronic conditions are generally associated with ageing. According to the AIHW, 
there are very few people over the age of 65, and none over the age of 85 with no 
chronic conditions (based on National Health Survey data). In the survey conducted 
by the Commonwealth Fund, 56% of those surveyed were aged 50 or older. Indeed, it 
appears that the number of chronic conditions rather than ageing per se, explains the 
increased use of health services by these older age groups (CHERE unpublished data). 
Nonetheless, chronic conditions are prevalent in every age group; almost 10% of 
children aged under 14 have three or more chronic conditions and the highest 
prevalence of asthma-related admissions is in this age group.  
 
The prevalence of chronic conditions is not evenly distributed across the population: 
Aboriginal and Torres Strait Islanders, the economically disadvantaged, and those 
living outside major cities are at higher risk. 
 
Chronic conditions vary in their severity from minor irritant to major disability and 
pain. Understanding severity represents a major challenge as the level of severity is 
likely to have an impact on management of the condition and costs. The major 
conditions listed previously (excluding depression) account for almost 50% of deaths. 
Most of these deaths occur over 65 years of age. The AIHW report does not present 
data on the morbidity and functional status associated with different conditions, 
although there are a number of data sources which could provide some estimates such 
as the National Health Surveys, the HILDA surveys and the 45 and Up survey in 
NSW.  
 
4.  The evidence for the prevention and management of chronic conditions 
Definitions 
Prevention is defined as primary, secondary and tertiary prevention.  
•  Primary prevention avoids the development of a disease. Most population-based 
health promotion activities are primary preventive measures.  
•  Secondary prevention activities are aimed at early disease detection, thereby 
increasing opportunities for interventions to prevent progression of the disease and 
emergence of symptoms.  
•  Tertiary prevention reduces the negative impact of an already established 
disease by restoring function and reducing disease-related complications.  
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For the purposes of this paper, tertiary prevention will be characterised as 
management (ie treatment and longer term care) of people with chronic conditions.  
 
In the table, the 12 major chronic conditions identified by the AIHW are defined 
together with identified means of primary and secondary prevention as well as 
management. It is important to note that the strategies or interventions listed in the 
table are not necessarily evidence-based. Further work is necessary to systematically 
evaluate the types and levels of evidence used in the studies conducted so far, 
including that for effectiveness and cost-effectiveness. Whilst some interventions 
have been shown to be effective and/or cost-effective, others have not been evaluated 
from this perspective.  
 
Much of primary prevention aimed at these conditions centres on the adoption of a 
healthy lifestyle, characterised by a healthy diet, regular exercise, avoidance of 
smoking and limited intake of alcohol. In addition, it includes specific strategies to 
ensure good sexual health such as understanding the physical, social and emotional 
changes that come with puberty, pregnancy and ageing and how to avoid sexually 
transmitted infections and blood borne viruses; and to maximise mental health, 
defined as a state of well-being in which the individual realizes his or her own 
abilities, can cope with the normal stresses of life, can work productively and 
fruitfully, and is able to make a contribution to his or her community.  
 
Whilst governments and the health system (particularly those aspects involved in 
implementing public health and health promotion interventions, strategies and 
programs) are responsible for informing the population about how to maximise good 
health and avoid poor health, such work may or may not involve the provision of 
health care services directed at individuals. Some services focus on providing 
information and education (and recently, individual “coaching”) aimed at encouraging 
behaviour change at a population level (eg health promotion campaigns) and 
implementing policies aimed at maximising and monitoring the public’s health (eg 
immunisation provision, monitoring environmental health and infectious diseases). 
Others include personal services in some aspects eg asking GPs to recommend their 
patients attend a screening service and/or provide educational material for GPs to 
discuss with patients in the target group. 
 
Much primary prevention is delivered outside the health care system (eg via media 
campaigns, in schools and via community-based organisations). On the other hand, 
within the health care system, most health services directed at chronic conditions are 
delivered on an individual basis by health care providers with the aim of treating ill-
health and preventing future reoccurrence and/or complications. That is, their 
objectives centre on secondary prevention and management. The remainder of this 
paper will focus on the evidence available regarding the optimal means of providing 
such services, including the issues for which there is no or limited research-based 
information.  
 
The overall issue to be addressed is how can the health system use appropriate levers 
(eg incentives, agreements, funding methods etc) to facilitate and incentivise the best 
quality and amount of care in terms of both prevention and treatment of symptoms. 
  8 
 
4.1  Health system level initiatives 
At the system level, the major stated objective for services directed at the secondary 
prevention and management of chronic conditions is coordination and/or integration 
of care. Whilst the features may vary with different conditions, a common set of 
characteristics of coordinated care has been described as the provision of: 
•  A care coordinator, usually a registered nurse who undertakes needs assessment 
and draws up individual care plans 
•  Patient education regarding adherence to the care plan, particularly prescribed 
medications, lifestyle changes, testing and monitoring regimens etc. Such 
education may be delivered using traditional means (eg lectures, booklets) or 
using motivational techniques 
•  Improved coordination of services through enhanced communication between 
providers, patients and carers, particularly around the transition of care between 
care sectors (ie primary, secondary, community etc) and the management of 
polypharmacy. 
 
Research from the US provides some information about the characteristics of well 
managed services for chronic conditions. Key features seem to be an organisational 
structure which facilitates the identification of high risk chronic disease patients and 
the co-ordination of care across a spectrum of services, without the barriers of rigid 
funding. The VA provides an exemplar; the VA provides comprehensive health care 
to military veterans and has developed models of co-ordinated care which are 
considered best practice in providing high quality and efficient service delivery. 
 
Only limited information is available from evaluative studies of how other funding 
and/or delivery systems (eg US Medicaid or demonstration “Medical Home” projects) 
respond to the challenges of managing chronic care. What information there is 
indicates that there is very little evidence that the provision of coordinated care saves 
money (ie in terms of reduced utilisation of services, medications etc). A review of 
the evidence generated from research so far indicates that while patients and carers 
are more knowledgeable, overall, in those programs which have been evaluated, 
neither behaviour, function nor health-related quality of life improved. Programs with 
substantial contact between patients and a case manager were more likely to be cost-
neutral (Peikes et al 2009).  
 
Fisher (2008) has suggested that whilst expectation about the benefits of systems such 
as the medical home are high (eg savings in health care costs, reversing the decline in 
interest in primary care amongst medical students and young physicians), there are 
several important barriers that need to be addressed if proposed new models of care 
are to love up to their promise. For example, it is not clear that there are incentives for 
collaboration amongst different providers and sectors; if incentives are directed at one 
sector or type of provider (eg primary care), others may oppose or not cooperate with 
the scheme, particularly if their funding or income is threatened.  
 
These issues largely mirror those reported in the evaluation of the Australian 
coordinated care trials. The observation that people with chronic conditions in 
Australia often face challenges in finding the right services and paying for them 
within the context of a health system which provides a diffuse set of services which 
are often duplicated under different funding arrangements, provided the rationale for 
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the implementation of the co-ordinated care trials. In the trials, funds from Medicare, 
PBS and State services could be pooled and the role of the co-ordinator was to ensure 
the appropriate delivery of services, irrespective of the sector. Results from the early 
trials demonstrated that co-ordination alone would not simply ensure better health 
outcomes and reduced cost of services. In fact, the early trials identified more gaps in 
care, than duplication. The results from the second round of trials show that care 
coordination appears to promote overall health awareness, diagnosis and self-
management of conditions.  These findings may eventually lead to a reduction in 
hospitalisations compared to usual care but this has not been established yet. 
 
Shared care is an earlier and more limited form of coordinated care, often, but not 
exclusively, directed at diabetes management. A recent Cochrane review of shared 
care found that there was no evidence that any aspects of utilisation, outcomes or 
costs improved except for a general improvement in prescribing (where this was 
evaluated) (Smith et al 2008).  However, the idea of shared care may be becoming 
redundant as it is not multidisciplinary (it typically only includes general practitioners 
and specialist medical practitioners), particularly as primary care becomes more 
multidisciplinary. 
 
The English NHS has moved to organise management for chronic conditions as a 
three tiered model consisting of self-management, disease management and case 
management.  
 
•  Self management is designed to focus on generic, rather than disease-specific 
skills and to be delivered by trained lay-people. Ham (2008) contends that despite 
some positive results from initial evaluations, most people with the potential to 
benefit will not have been able to access such a program as limited resources have 
been directed towards it. Some disease-specific self-management programs are 
available from the NHS (eg for diabetes) and from non-government organisations, 
but these are also limited in scope. 
 
•  Disease management is designed to be delivered through a primary care-led team 
and includes disease registries, regular patient review and achievement of specific 
processes of care (compared with guidelines) and outcomes (eg control of 
hypertension). The introduction of this model of care has been facilitated by 
specific aspects of primary care in England – registration of patients with one 
practice, the expectation that this practice will be the first point of contact for 
patients and the ability of most practices to provide comprehensive, often 
multidisciplinary care to their registered patients. The development of the 
electronic medical record and the absence of financial barriers have also assisted 
the introduction of disease management. Nurses do much of the work associated 
with disease management. The Pay-for Performance contract introduced in 2004 
has introduced incentives for GPs to enhance the quality of care provided for 
chronic conditions. Results from evaluations show that a high level of 
achievement in relation to both process and outcomes was attained after one year 
and sustained in subsequent years and inequities in access were reduced. The 
evaluation also indicated that GPs’ incomes increased 58% between 2002-03 and 
2005-06 and that payments to GPs represented the most expensive element of the 
overall chronic care policy. More conditions and indicators have been included in 
a subsequent contract. The development of national services frameworks to set 
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standards for the quality of care and the continuing appraisal of new drugs and 
technologies as well as the development of guidelines by NICE has supported the 
disease management efforts. 
 
•  Case management is designed for patients with complex needs, generally 
requiring intensive support. The objective of case management is to enable people 
(mostly elderly) with a range of chronic conditions to continue to live at home. 
Although preliminary evaluation of pilot projects in the UK indicates that case 
management is unlikely to save resources (in terms of emergency admissions to 
hospital, bed days) or lives, it is considered the most appropriate means of 
delivering high quality services in an effective manner. Identified benefits include 
management of polypharmacy to prevent adverse reactions, coordinating care and 
arranging access to community-based services. The provision of case management 
has been shown to be highly valued by recipients and their carers. A predictive 
tool (Patients at Risk of Re-Hospitalisation, PARR) has been developed although 
examples of its use have not be identified. 
 
In Australia, Swerissen and Taylor (2008) have suggested a regional model of funding 
and care provision ranging from medical (GP) management only for patients with an 
uncomplicated clinical and psychosocial profile, to medical management plus 
multidisciplinary care (MDC) for patients with a more complex clinical profile (eg 
multiple risk factors and/or chronic conditions) to medical management plus MDC 
plus social support for patients, who, in addition to presenting with a complex clinical 
profile, also have psychosocial issues requiring more services than medical, nursing 
and allied health professionals can provide eg home care or community support 
services. The implementation of this model of care, whose levels can be seen to be at 
least partly aligned with the UK’s levels of self-management, disease management 
and case management, would require system level initiatives to realign and extend the 
current Medicare chronic disease management programs, the adoption of a cross-
system model of outcomes-based funding and the integration of social support 
services with health services.  
 
The Council of Australian Governments (COAG) has identified that people with 
complex chronic disease (ie they have serious disease, often more than one condition, 
and have a history of very high levels of health care utilisation) experience problems 
in relation to timely access to and continuity of care between the number and range of 
health and community care services they need. This group is estimated to represent 
approximately 3% of the population. COAG’s proposed solution is a disese 
management model of care, consisting of four components: 
•  Identification and registration/enrolment of patients who meet specific criteria; 
•  The development of an evidence-based shared health plan for each patient; 
•  The use of care coordinators or health coaches working mainly by telephone, to 
support patients and carer/s self-management and to coordinate and monitor 
implementation of the shared care plan; and 
•  Integrated I&CT systems to support clinical decision making, central collection of 
information and secure sharing of information between providers, services and 
sectors. 
In developing these recommendations, COAG recognised that significant barriers 
exist in Australia to its immediate implementation in terms of the lack of a 
standardised e-health system and constraints around workforce supply. No 
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information is available about the extent to which such a system is currently operating 
in Australia or whether COAG’s recommendations have been implemented in any 
jurisdiction. 
 
4.1.1 Evaluations  of  system-level initiatives 
Eliaszadeh et al (2001) undertook a cost-benefit analysis of a disease management 
program for CHF implemented in one hospital in Connecticut. A before-and-after 
design was used. Results at 12 months following the implementation of the program 
indicated that the program significantly reduced costs of care, ER visits and length of 
stay. However, as it was undertaken in one hospital only, enrolled only a small 
number of patients and utilised an uncontrolled design, the results from this study 
should be treated with caution. 
 
An evaluation of a randomised trial in Indianan USA for Medicaid recipients with 
diabetes, congestive heart failure (CHF) or both which compared an intensive nurse 
care management program for high risk patients and a less intensive telephonic 
program for low risk patients with usual care, found that cost savings were achieved 
in CHF patients who received the telephonic intervention (ie low risk group) (Holmes 
et al 2008). Medicaid claims were lower for low risk diabetes patients (telephonic 
intervention) and high risk CHF patients (intensive nurse management) but no cost 
savings were achieved. Amongst high risk diabetes patients claims were higher for the 
intervention group (intensive nurse management) compared to usual care.  
 
Zhang et al (2007) evaluated the costs and outcomes of a chronic disease management 
program on the costs and outcomes of Medicaid recipients in Virginia using a pre- 
and post-quasi experimental design. Physicians and pharmacists were mailed 
quarterly for three years with educational material, claims feedback, and the latest 
results of the program which was targeted at 5 chronic conditions (diabetes, CHF, 
depression, gastro-oesophogeal reflux (GERD), peptic ulcer and COPD. Results 
indicate that GERD, peptic ulcer disease and CHF are the best candidates for single 
disease management programs as measured by reductions on ER visits, 
hospitalisations and prescriptions. The program enabled patients with multiple co-
morbidities to reduce adverse drug events and the use of drugs and hospitalisations. 
The study also demonstrated that while some patients may increase their utilisation of 
services, if office consultations replace ER visits and hospitalisations, the overall 
result may be cost saving. Whilst this was a non-randomised study, the experimental 
and control groups were matched on risk factors and disease states, more than 7000 
physicians and pharmacists participated and information was obtained from more than 
35,000 patients. Thus, its results are more credible than the previously described 
evaluation. 
 
4.2  Health service level initiatives 
At the health service level, the major objective of implementing a model of care for 
one of more chronic conditions is to manage risk factors and/or established disease to 
prevent deterioration.  
 
The most influential model described in the literature is that developed by Wagner 
and colleagues called the Model for Effective Chronic Illness Care (1996, 1999).  
This model has influenced many providers and decision makers in this area. The 
original model was developed using a process of literature synthesis and expert 
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review. Later revision of the model was informed by site visits to facilities and 
organisations which claimed to be using the model and by surveys of users and 
experts. Focused at the health services delivery level, its main requirements are the 
development of:  
 
•  informed, activated patients; and  
•  prepared, proactive, professional teams of providers.  
 
The formation of such a team requires the establishment of information systems 
around reminders, feedback etc, explicit plans and practice protocols around roles of 
the members of the team, close attention to appointments and follow-ups for patients 
who need additional time, provider training using education and decision support 
systems, including reminders and feedback, as well as the means to actively involve 
the patient, using education regarding the condition, self management and behaviour 
change. A more recent version of the model (Wagner 1999), recognises the need to 
have in place an appropriately organised and resourced health system (ie taking into 
account such factors as incentives and leadership) as well as community resources (ie 
the capacity to effect and support self-management) to support the required changes at 
both practice and provider level. It was also recognised that the original version did 
not indicate the mechanisms through which the model operated to produce better 
process and outcomes (ie the theoretical basis of the model was incomplete). The 
revised model proposes that productive interactions are such mechanisms and through 
these, improved outcomes such as better clinical care, health status, patient 
satisfaction, utilisation and cost will be achieved.  
 
Wagner and colleagues (1999) have described a number of programs as effective 
users of the model: a multidisciplinary team-based program aimed at reducing 
hospitalisations amongst patients with congestive heart failure (CHF); a primary care 
health cooperative-based system aimed at delivering high quality care to patients with 
diabetes, heart disease and depression through primary care; an HMO-based system of 
structured group-based interventions aimed at improving patient care and provider 
satisfaction for elderly patients with chronic conditions who were high users of the 
organisation’s services; and a program using nurses as case managers for patients with 
diabetes. However, effective programs, while using the model successfully as a 
“checklist” to ensure all areas are being addressed, were limited in their reach and 
effectiveness in terms of health outcomes. Most were serving a minority of the 
population using pilot programs, reported weak links between primary and secondary 
care. The mechanisms by which the most successful programs operated were seen to 
be i) rigorous use of guidelines and protocols, supported by systems such as 
reminders, case managers, specialist involvement in care, ii) more intensive follow-up 
usually involving telephone calls which led to iii) earlier identification of patients 
needing more intensive or specialised treatment and iv) use of “modern” self-
management approaches rather than traditional patient education. 
 
4.2.1 Evaluation  of  service-level initiatives 
The more precisely the objectives of a service can be described, the easier it is to 
identify potential options which will meet those objectives. For example, for people 
with diabetes, the objective of a disease management model of care (which may be 
equivalent to medical management plus MDC in this case) may be to prevent the 
development of complications such as retinopathy and peripheral vascular disease 
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(leading to blindness and amputation). For those who already have such 
complications, the objective of a case management model (which, depending on the 
circumstances of the patient may be equivalent to medical management plus MDC +/- 
social support) may be to enable them to maintain maximum independence at home.  
 
As the aim of health services is to provide the most cost-effective means of meeting 
these objectives, it is necessary to assess the costs and benefits (outcomes) of 
providing each option, including how either or both are likely to differ between high 
and low risk groups. In many cases, the alternative options identified for secondary 
prevention and/or management will include some strategies which overlap with for 
primary prevention- the difference being that the strategies are delivered within the 
health care setting.  
 
The first step in assessing costs and benefits is to evaluate the relative effectiveness of 
alternatives. A systematic review of 560 published and unpublished studies including 
RCTs and reviews regarding the evidence about programs aimed at improving the 
care for people with chronic conditions has been undertaken by the Surrey and Sussex 
Primary Care Trust Alliance (Singh et al 2005). The results indicate that such 
initiatives can enhance satisfaction with care, quality of life and, in some cases, 
utilisation of services. Initiatives that appear successful include the following: 
•  Broad management models 
•  Integrated community and hospital care 
•  Primary care-led models 
•  Targeting patients at high risk of complications and hospitalisation 
•  Involvement of patients in decision making 
•  Providing accessible structured information for patients, carers and families 
•  Education in self-management 
•  Systems that encourage self-monitoring and self-referral 
•  Electronic and telemonitoring 
•  Nurse-led strategies, where appropriate 
 
The review found that there was less evidence to support case management, evidence-
based pathways or protocols or shared learning for health care professionals and 
limited information was available about models for commissioning services and 
linking health services with voluntary and community services. 
 
A review of chronic disease management options (excluding mental health 
conditions) in the primary care setting in Australia (Dennis et al 2008) found that 
interventions most likely to be effective were education and training for primary care 
providers in self-management support and including this element of care in care plans 
for multidisciplinary care. It also found that Practice Incentive Payments (PIPs) and 
Services Incentives Payments (SIPs) could be improved to facilitate the use of 
guidelines and to recognise the need to integrate the management of patients with 
more than one chronic condition (ie not to manage them as if they had a series of 
separate chronic conditions). The use of disease registers should be expanded. 
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5.  The challenge of providing prevention and management interventions, 
services and programs for chronic conditions 
 
Chronic diseases are expensive, with the Australian National Chronic Disease 
Strategy attributing 70% of total health care expenditure to chronic disease. The 
extent to which this estimate is credible depends on the definition of chronic 
conditions. For example, this estimate includes the cost of treating injuries; while 
some injuries have long term consequences for disability and impairment, others are 
resolved after an acute episode. Further, these estimates are based on ‘top down 
allocation’ where total expenditure is attributed to diseases.  
 
The top 12 conditions account for just over 20% of total health expenditure. Although 
care of chronic conditions involves all components of the health care system, hospital 
care is the largest component of the costs, accounting for around one third. How much 
of this is aimed at primary (preventing development of risk factors) or secondary 
prevention (managing risk factors to prevent or slow the development of clinical 
disease) is not identified. For example, the estimate for dental services includes all 
dentistry including primary prevention and cosmetic interventions. Thus examining 
only the costs of treatment (disease costs or costs of illness) is less useful for policy 
and planning than identifying what is preventable or avoidable (see the Table). 
 
It is likely that there is substantial variability across individuals with the same chronic 
disease in terms of patterns of expenditure and use. The lack of linked or panel data 
sets has meant this is difficult to investigate in most of Australia
1. To date, 
understanding the development of chronic disease over time, and the associated health 
care use and expenditure, has relied on the recruitment and follow up of specific 
cohorts. For example, CHERE has undertaken a longitudinal study of the utilisation of 
services and associated costs of a cohort of people with asthma (ref). This has shown 
that not only that there is substantial variability in terms of utilisation of services 
across individuals, but that those individuals with high health care use, particularly 
hospital admission, are more likely to remain high users and require further hospital 
admission. What is not clear from our data is whether the high users are people with 
much more severe asthma, or whether their condition is poorly managed. It should 
also be noted that the pattern of health services utilisation and costs, and the 
relationship between severity and utilisation in asthma may not be generalisable to 
other chronic conditions.  
 
The survey undertaken by the Commonwealth Fund (ref) also provides some 
information about where patients with chronic conditions face particular problems in 
the context of the Australian health system. Overall, respondents living in the USA 
faced the greatest barriers in terms of costs but Australia was second worst in terms of 
respondents reporting that they had not filled a prescription, seen a doctor or had a test 
because of the cost. Australia was also second worst in terms of same-day access to 
care and access to after-hours care (not ER care). Seventeen percent of respondents 
(the third highest rate) reported that they visited the ER for a condition that could 
have been treated by a doctor had one been available. In a similar vein, Australia had 
the lowest reported percentage of respondents waiting between one a two months to 
                                                 
1 WA is the exception as it has linked its health data with MBS and PBS data 
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see a specialist doctor, and the second lowest reported percentage waiting less than 
four weeks. Australians reported the lowest level of being able to obtain advice when 
they needed it.  
 
In the future, the more widespread availability of linked data and data from panel 
studies such as HILDA and the 45 and up study will facilitate better understanding in 
this area. In the meantime however, it is clear that costs and access to both after-hours 
primary care and timely specialist care are important issues for Australians with 
chronic conditions.  
 
There is also variability in the out-of-pocket costs associated with chronic disease. 
User charges may discourage patient compliance with treatment plans, leading to 
exacerbation of the condition and higher treatment costs. The evidence is strongest for 
the effect of co-payments for pharmaceuticals.  
 
The care of chronic disease is increasingly likely to involve a range of health care 
professionals, particularly as medicine becomes more specialised and as innovative 
services are proposed. Drug treatments often involve undesirable side-effects, for 
which more drugs can be prescribed, requiring patients to manage complex regimens. 
Similarly, a feature of chronic disease is that patients may be receiving multiple 
treatments for their condition, as the first and second line treatments become less 
effective over time. Chronic disease often requires the patient to understand their 
condition, monitor it, initiate or change treatment, and know when it is appropriate to 
seek further medical intervention. Further, the clinical outcomes or indicators used by 
medical practitioners may not accord with patients’ own perceptions of their health 
and well-being, thus encouraging patients to not adhere to prescribed treatments. Self 
management may require lifestyle changes. The management and care of chronic 
conditions affects patients’ families and carers.  
 
Chronic conditions do not occur in isolation. Patients will also suffer acute unrelated 
conditions which require treatment; and many have more than one chronic condition. 
This can lead to drug interactions and unintended consequences (including hospital 
admissions). Once a chronic condition is established, the challenge for health services 
is to maintain and improve patient outcomes through the efficient provision of health 
services.  
 
5.1  Framework for the secondary prevention and management of chronic 
conditions 
The information provided above, whilst incomplete, provides important indicators of 
what to include in a successful system, including funding, organisation and delivery 
arrangements which are likely to result in improved health care services (in terms of 
quality, safety and patient satisfaction) and outcomes (in terms of clinical indicators 
and quality of life) for patients.  
 
Beginning at the care delivery level, what seems to be needed are services which 
allow patients to be characterised in terms of the stage of the condition and whether 
they have risk factors for more than one condition, or more than one established 
condition. Once this information is systematically recorded, services require 
organisational support and funding mechanisms to be in place which will enable the 
appropriate type and intensity of care to be delivered, bearing in mind that different 
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levels of care will involve different mixes of care ranging from self management, 
through disease management to case management. Finally, support at the 
State/Territory and National levels in terms of overall funding arrangements, 
guideline and protocol development, IT initiatives to facilitate the development of 
electronic registration, storage and communication systems and workforce 
development will be necessary. 
  
5.1.1  Funding and organisational arrangements at the service level 
There are two key elements required in developing appropriate models for organising 
and delivering care for chronic conditions. The first is to understand the condition and 
define best practice care for both secondary prevention and management. This 
requires determining the components or individual services required for a particular 
disease and evidence supporting their effectiveness and cost-effectiveness in 
managing the progress of the condition in terms of managing risk factors and 
preventing or reducing complications. Clinical guidelines have been developed for 
both acute and chronic conditions, but there is evidence from a range of countries that 
guidelines generally are not well taken up.  
 
Therefore a second key element required is the structure of service delivery that will 
provide those components of best practice care. This is likely to be largely 
generalisable across diseases, though there may be some specific variations; it is also 
likely to vary across geographical areas and should be coherent with the existing 
pattern of service delivery. It requires decisions regarding the nature of the services to 
be provided (eg self-management, disease management or care management or some 
other model of care provision) attention to incentives, both for practitioners in 
prescribing the appropriate care, and in ensuring adequate access (geographic, 
financial). A number of elements are key to this, and incentives will also be needed to 
ensure that these issues are addressed systematically:  
 
•  Determine the objectives of the program. For example, if the program is targeted 
at reducing hospitalisations in the short term, then it will focus on the currently 
severe group undergoing multiple admissions now. On the other hand, if it targets 
the stabilisation of a chronic condition, it will focus on preventing any worsening 
of the condition and potentially preventing multiple hospital admissions in the 
future. 
•  Understand the current infrastructure for chronic disease care. This requires 
identifying what already exists, in terms of primary care, hospitals and private 
insurers. It encompasses the workforce and identifiable programs.  Then a new 
program can leverage from what exists rather than imposing another edifice. 
Likely differences across regional Health Services and even within each region 
should be considered. 
•  Understand what does not work in current programs. This should encompass 
national initiatives such as those on asthma and diabetes. This should look for 
whether there are groups of people for whom this approach has not worked. This 
should also show whether interventions which have been successful in one context 
do not transfer to another, eg programs designed in an urban setting may not work 
in a rural setting; programs developed and implemented by a highly motivated and 
charismatic leader my not be as effective when transferred to another team. 
•  Determine the structure of the program. This should specify  
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•  the role of the general practitioner and other medical providers with whom 
the patient has an ongoing relationship 
•  the role of any care planner or co-ordinator 
•  the point of identification of cases 
•  the role of education or health coaching 
•  the process for the provision of evidence based guidelines, and other tools 
•  medico-legal responsibility 
 
The role of education or coaching is crucial as chronic care management can be 
improved through self-management and/or partnerships between providers and 
patients. The idea of health coaching is a further development of the practice of 
individualised support to enhance work, business and life performance which gained 
popularity over the 1990s. This in turn is building on the metaphor of sports coaching. 
Health coaching aims to provide information and support in changing attitudes and 
behaviours. Palmer et al, writing in 2003, commented on the lack of published 
evidence on the effectiveness of this approach. The extent to which evidence has been 
developed since that time requires a substantial review of the published literature. 
However, it has grown in popularity both within health promotion and with life and 
health coaches in private practice. Again, an important aspect is ensuring that there 
are not inconsistent messages or advice, and dealing with all aspects of a patient’s 
care requirements rather than focussing on only one condition. Taking account of the 
input from and needs of any informal carers is also likely to be critical to the success 
of any educational or coaching programs. 
 
Depending on the structure chosen, chronic care case management may come from 
the GP, the specialist, the specialist case co-ordinator or an educator. Whatever model 
is chosen, there is a need for tools, including but perhaps not limited to, evidence 
based guidelines. The existing literature is large, and is likely to be growing rapidly. 
Therefore any program must be supported by a process for assessing evidence and 
providing these tools to the case manager.  
 
5.1.2  Organisational and delivery arrangements at the system level 
The advantages of comprehensive, continuing care are the established relationships 
between provider and patient, common record keeping, co-ordination of all care, and 
when set within a wider organisational context, the ability to draw on specialised 
knowledge and experience. However, as the Co-ordinated Care Trials have shown, it 
is difficult to graft this type of model onto the current structure of the Australian 
system and to realise cost savings. 
 
Many countries have initiated changes to funding (eg specific incentives, bundled 
payments), systems to enhance the storage, provision and exchange of information (eg 
registries, electronic medical records, telehealth etc) and increased emphasis on self-
management when appropriate. Australia, however, seems to have failed to grasp the 
nettle. 
 
There is growing interest in the US in enhancing the role of primary care in a 
management and co-ordination function. The term ‘medical homes’ has been applied 
to describe this function, where this encompasses not just the primary care doctor as a 
gatekeeper, but a provider that is accessible after hours and at weekends, and does not 
just refer but co-ordinates and manages care. The Commonwealth Fund states that this 
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requires a change from fee for service payment, and an underlying information 
technology base. 
 
In the UK, recent reforms have focussed on primary care and general practice in 
restructuring through the establishment of Primary Care Trusts, and providing 
incentives for better performance through the Quality and Outcomes Framework. This 
sets a large number of performance measures, across a range of diseases, with 
financial rewards for achievement.  
 
This approach has, to some extent, been adopted in Australia. Initiatives such as the 
Practice Incentives Program, the Service Incentives Program and Enhanced Primary 
Care and Chronic Disease Management have been implemented with new items 
available under Medicare MBS. No evaluative studies of these initiatives have been 
identified and this is a potential area for new research and evaluation projects. These 
initiatives have not been introduced as part of a coordinated program of changes and 
their objectives in terms of managing chronic conditions have been largely directed at 
GPs, who, whilst important providers of care, are not the sole providers of care for 
people with chronic conditions. Thus, in terms of organisational change, these 
initiatives can be regarded as marginal at best, so it is not surprising they do not 
appear to have led to major improvements in the care of chronic conditions. Ham () is 
of the opinion that in order for substantive changes to occur, it is necessary to act on 
several fronts at once ie strengthen the capacity of primary care to deal with chronic 
conditions, initiate a system-wide framework such as the one previously described 
involving self-management, disease management and care management. Both Ham 
and the Commonwealth Fund recommend that ways be found to decrease the 
divisions between primary and secondary care so that the common goals (eg reducing 
unnecessary hospitalisations and increasing the integration of care) are the goals of all 
levels of the system. 
 
In the Australian system, the GP still has a primary role in the comprehensive care of 
individual including those with chronic disease. However, once individuals have 
established chronic disease they are likely to have a relationship with other specialists, 
often these involve ongoing care. Across health care systems, patients have reported 
difficulty in receiving treatment and advice from a range of professionals, as this can 
led to inconsistent advice and interactions of therapies. Hence the role of existing 
providers has to be considered.  
 
Further, medical practitioners are the access point to MBS and PBS funded services. 
These services should continue to be used appropriately, and not fund services that 
can be funded form these programs. The care co-ordinator role has to be designed to 
co-ordinate not to add another inconsistent source of advice. Care co-ordinators could 
take a separate role to medical providers; alternatively they could work in a 
supplementary role, supporting care providers. 
 
No one country has been able to outline a truly successful solution to the issue of 
preventing and managing chronic conditions. Although the framework above begins 
at the level of service delivery, crucial system-wide issues such as i) increased 
cooperation between primary and secondary care, ii) increased use of practice nurses 
and other non-medical providers as case managers, iii) enhanced multidisciplinary 
teamwork and iv) the provision of s sophisticated IT network will not be solved at the 
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practice or service organisation level. They require a national response. The most 
important response should be in terms of funding and incentives to address issues i) to 
iii) as issue iv), the IT system, is a tool for the use of service providers and managers. 
Reform of the funding and incentive system currently in place is seriously hampered 
by what Hickie (2009) has described as “basic financial and professional distortions” 
more in line with a 19
th rather than a 21
st century health system.  
 
Australia has experienced one major reform of the health system with the introduction 
of Medicare, originally in 1973. Unfortunately, in subsequent years, the necessary 
political leadership has been lacking to undertake further fundamental reforms to 
funding arrangements to provide incentives which will allow integrated teams of 
health professionals to work and communicated together and with patients to provide 
care across primary and secondary care, at home or in hospital and to facilitate the 
coordinated and collaborative use of electronic communication systems.  
 
6.  Summary of Issues 
A national response in cooperation with States and Territories is needed to identify 
and provide funding solutions (particularly in terms of the structure of reimbursement 
and incentives for providers) to address such issues as how to facilitate increased 
cooperation between primary and secondary care, increased use of practice nurses and 
other non-medical providers as case managers, enhanced multidisciplinary teamwork 
and the provision of s sophisticated IT network. 
 
At national, State/Territory and local organisation level, attention needs to be paid to 
the issue of guidelines. Clinical guidelines have been developed for both acute and 
chronic conditions, but there is evidence from a range of countries that guidelines 
generally are not well taken up. Therefore a second key element required is the 
structure of service delivery that will provide those components of best practice care. 
This is likely to be largely generalisable across diseases, though there may be some 
specific variations; it is also likely to vary across geographical areas and should be 
coherent with the existing pattern of service delivery. It requires decisions regarding 
the nature of the services to be provided (eg self-management, disease management or 
care management or some other model of care provision) attention to incentives, both 
for practitioners in prescribing the appropriate care, and in ensuring adequate access 
(geographic, financial). 
 
Specifically at the organisational and service delivery levels, important issues which 
need to be addressed include how to identify and “stage” individuals with chronic 
conditions, the development and implementation of guidelines (including what 
resources are required for this and what incentives are needed) and the development, 
implementation and use of specialised IT systems to facilitate the coordination of care 
and the evaluation of both processes and outcomes of health care delivery. 
 
7.  Potential Research Agenda 
The research agenda outlined below is drawn from the issues identified in this 
Working Paper. The list is by no means comprehensive and can be adjusted at any 
time. 
1.  What are chronic conditions? 
•  What is the proportion of individuals with one, two, three or more chronic 
conditions? 
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•  What are the socioeconomic and sociodemographic characteristics of 
individuals with one, two, three or more chronic conditions? 
•  Can the utilisation of health services be described for each group and has 
utilisation change over time (if possible for the same individuals but also by 
comparing cross sectional surveys) 
•  What OOP costs are faced by individuals in each group and overall and have 
these changed over time? 
 
2.  What is the evidence about preventing and managing chronic conditions? 
•  The information provided in the Table is preliminary. There is a need to 
systematically evaluate the types and levels of evidence used in the studies 
conducted so far, including that for effectiveness and cost-effectiveness. 
•  Using data from panel data sets to describe patterns of care for chronic 
conditions, particularly in terms of the predictors of high and low use of 
medical and hospital services. 
•  Expand the analysis of the Commonwealth Fund survey eg to describe and 
characterise respondents such as the 26% who reported that their care was 
poorly organised and the 53% who visited the ER in the past 2 years. 
 
3.  What are the challenges for the Australian health system in terms of preventing 
and managing chronic conditions? 
•  How well have funding incentives such as the Practice Incentives Program, 
the Service Incentives Program and Enhanced Primary Care and Chronic 
Disease Management worked in terms of preventing and managing chronic 
conditions?  
•  What funding reforms and incentives around provider reimbursement are 
likely to be successful in enhancing the performance of providers in relation to 
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Table: Chronic conditions and interventions aimed at preventing and managing them 
Condition  Definition  Primary prevention  Secondary prevention  Management 
Arthritis   Arthritis means inflammation of a joint. There are 
more than one hundred different forms of 
arthritis. They are similar to each other in the 
symptoms they produce, which includes sore, 





Adequate strengthening & 
flexibility exercises 
Weight loss 





Asthma  Asthma is a chronic lung disease. It is disorder of 
the airways that is complex and characterized by 
variable and recurring symptoms, airflow 
obstruction, bronchial hyper-responsiveness 
(bronchospasm), & an underlying inflammation. 
The interaction of these features of asthma 
determines the clinical manifestations & severity 









Asthma management plan 







Any abnormal condition characterized by 
dysfunction of the heart & blood vessels. CVD 
includes atherosclerosis (especially coronary heart 
disease, which can lead to heart attacks), 
cerebrovascular disease (eg, stroke), & 









Manage risk factors: 
•  Hypertension 
•  Dislipidaemia 








All interventions as for primary and 
secondary prevention PLUS 
•  Surgery (eg stents, CABG etc) 
•  Cardiac rehabilitation 
Cerebrovascular 
disease 
Disease of the blood vessels &, especially, the 
arteries that supply the brain. Cerebrovascular 
disease is usually caused by atherosclerosis & can 








Manage risk factors: 
•  Hypertension 
•  Atrial fibrillation 
 
All interventions as for primary and 
secondary prevention PLUS 
•  Medical management of acute 
CV events eg stroke 
•  Rehabilitation post stroke 
                                                 
2 Adequate nutrition = adhering to nutritional guidelines regarding intake of meat, vegetables, fruit and dairy products; limiting fat and sugar intake, particular foods regarded 
as energy dense and sweetened drinks. 
3 Adequate exercise = adhering to recommendations provided by experts in relation to aerobic and strengthening exercise. The current recommendations are that adults 
undertake at least 30 minutes of moderate intensity physical activity on most, preferably all, days and, if possible,  incorporate some regular, vigorous activity. 
4 Current recommendations for intake of alcohol are that on average men consume no more than four standard drinks a day, and women no more than two. On any single 
occasion, men should consume no more than six drinks and women no more than four. One or two days a week should be alcohol free. 




Chronic kidney disease (CKD), also known as 
chronic renal disease, is a progressive loss of 








Medical intervention to 
delay progression of kidney 
failure 
Medical management of kidney 
failure 
•  Drug therapy 






Refers to chronic bronchitis and emphysema, two 
commonly co-existing diseases of the lungs in 
which the airways become narrowed This leads to 
a limitation of the flow of air to & from the lungs 
causing shortness of breath. The limitation of 
airflow is poorly reversible & usually gets 
progressively worse over time. 
Avoid smoking 
Avoid occupational & 
environmental pollution 
Manage asthma  
Manage episodes of 
bronchitis and other 
infections 
Vaccinate against influenza 
Avoid infections through 
use of good hygeine 
Medical management of COPD 
using drugs and supplemental 
oxygen 
Manage acute exacerbations by 
avoiding infections (eg flu 




Colorectal cancer  Colorectal cancer, also called colon cancer or 
large bowel cancer, includes cancerous growths in 
the colon, rectum and appendix. Many colorectal 
cancers are thought to arise from adenomatous 
polyps in the colon. These mushroom-like 
growths are usually benign, but some may 


















radiotherapy as indicated by 
published guidelines 
Diabetes  A syndrome of disordered metabolism, usually 
due to a combination of hereditary and 
environmental causes, resulting in abnormally 















Foot examination and care 





Foot examination and care 
Care of established complications 
(eg retinopathy, vascular disease) 
according to published guidelines. 
Lung cancer  Lung cancer is a disease of uncontrolled cell 
growth in tissues of the lung. This growth may 
lead to metastasis, which is the invasion of 




Avoid environmental & 
occupational smoke 
No definitive strategies 
identified 
? Quit smoking 
Surgical, chemotherapy & 
radiotherapy as indicated by type of 
cancer & published guidelines. 
  24  
  25 
The vast majority of primary lung cancers are 
carcinomas of the lung. 
Oral disease  Oral disease refers to a number of inflammatory 
diseases affecting the periodontium — that is, the 
tissues that surround and support the teeth.  
Periodontitis involves progressive loss of the 
alveolar bone around the teeth, & if left untreated, 
can lead to the loosening and subsequent loss of 
teeth. Chronic Periodontitis, the most common 
form of the disease, progresses relatively slowly 








Clean teeth & gums regularly 
Clean teeth & gums 
regularly 
Avoid excess consumption 
of sugar 
Avoid smoking 
Limited alcohol intake 
Dental treatment 
Clean teeth & gums regularly 
Avoid excess consumption of sugar 
Avoid smoking 
Limited alcohol intake 
Osteoporosis  Osteoporosis is a disease of bone that leads to an 
increased risk of fracture. In osteoporosis the 
bone mineral density (BMD) is reduced, bone 
microarchitecture is disrupted, & the amount and 
variety of non-collagenous protein in bone is 
altered. 
Ensure sufficient intake of 









Vitamin D supplements 
Calcium supplements 
Drug treatment to prevent 
further bone loss and 
fractures 









Depression  Depression is a common mental disorder that 
presents with depressed mood, loss of interest or 
pleasure, feelings of guilt or low self-worth, 
disturbed sleep or appetite, low energy, & poor 
concentration. These problems can become 
chronic or recurrent & lead to substantial 
impairments in an individual's ability to take care 
of his or her everyday responsibilities. At its 
worst, depression can lead to suicide. 
No definitive strategies 
identified 
It is difficult to prevent all 
recurrences of depression. 
However, it may be 
possible to prevent or 
reduce the severity of 
future episodes using by 
prescribed medication, 
CBT, exercising regularly, 
ensuring good nutrition & 
avoiding alcohol & drugs. 
CBT 
Prescribed medication 
Regular exercise 
Good nutrition 
Avoid alcohol 
Avoid drugs 
 
  
 
 